Preterm birth and birthweight-for-gestational age among immigrant women in Denmark 1978-2007: a nationwide registry study.

BACKGROUND: We sought to examine whether age at immigration and length of residence were associated with preterm and small-for-gestational age (SGA) delivery among immigrant women in Denmark. METHODS: We included all live singleton deliveries from Danish-born women (1626880) and women from the five largest immigrant groups (68936) from 1978 to 2007. Data from the Danish Medical Birth Registry were linked to: parental country of origin, length of residence and age at immigration. Linear and logistic regression models were used to estimate absolute and relative differences with Danish-born women as the reference group. RESULTS: All immigrant groups had an increased risk of SGA delivery with the highest risk among Lebanese-, Somali- and Pakistani-born women: risk differences (RDs) and 95% confidence intervals [CI] per 1000 deliveries of 50.2 [95% CI 43.7, 56.7], 70.1 [95% CI 62.2, 77.9] and 85.7 [95% CI 78.5, 92.9]. Turkish- and Pakistani-born women had increased RDs of 1.8 [95% CI 0.5, 3.1] and 2.2 [95% CI 0.1, 4.2] for very preterm and RDs of 3.5 [95% CI 0.9, 6.1] and 10.2 [95% CI 5.9, 14.5] for moderate preterm delivery. Lebanese-born women had a decreased risk of very preterm delivery, RD of -1.9 [95% CI -3.5, -0.3] and Somali-born women a lower risk of moderate preterm delivery, RD of -7.8 [-12.0, -3.6]. No differences were seen for the remaining groups. The association with length of residence for most immigrant groups was U-shaped, with highest risks among recent and long-term residents. CONCLUSION: Immigration was more strongly related to SGA than to preterm delivery. Observed differences in birth outcomes varied by age at immigration and length of residency in Denmark.

Dietary acrylamide intake and estrogen and progesterone receptor-defined postmenopausal breast cancer risk.

Acrylamide, a potential human carcinogen, has been discovered in a variety of heat-treated carbohydrate-rich food products. Previously, dietary acrylamide intake was shown to be associated with endocrine-related cancers in humans. We assessed the association between dietary acrylamide intake and risk of postmenopausal breast cancer stratified by estrogen and progesterone receptor status. This study was embedded within the Netherlands Cohort Study on diet and cancer, which was initiated in 1986 enrolling 62,573 women aged 55-69 years at baseline. After 13.3 years of follow-up, 2225 incident breast cancer cases were ascertained, with hormone receptor status information for 43%. Cox proportional hazards analysis was applied to determine hazard ratios in quintiles of dietary acrylamide intake stratifying on estrogen receptor (ER) and progesterone receptor (PR) and smoking status. No association was observed for overall breast cancer or receptor-negative breast cancer risk, irrespective of smoking status. A statistically non-significantly increased risk of ER positive, PR positive and joint receptor-positive breast cancer was found in never-smoking women. The multivariable-adjusted hazard ratios were 1.31 (95% CI: 0.87-1.97, P (trend) = 0.26) for ER+, 1.47 (0.86-2.51, P (trend) = 0.14) for PR+, and 1.43 (0.83-2.46, P (trend) = 0.16) for ER+PR+, when comparing women in the highest quintile of acrylamide intake (median 36.8 microg/day) to women in the lowest (median 9.5 microg/day). This study showed some indications of a positive association between dietary acrylamide intake and receptor-positive breast cancer risk in postmenopausal never-smoking women. Further studies are needed to confirm or refute our observations.